Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anabella Smulever"'
Autor:
Alvaro Sanabria, Carolina Ferraz, Chih Hao Chen Ku, Rosalia Padovani, Karen Palacios, José Luis Paz, Alejandro Roman, Anabella Smulever, Fernanda Vaisman, Fabian Pitoia
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 68 (2024)
ABSTRACT The incidence of thyroid cancer is increasing globally, but mortality rates have remained steady. Many patients with thyroid cancer have low-risk, nonmetastatic intrathyroidal tumors smaller than 2 cm. Active surveillance has shown benefits
Externí odkaz:
https://doaj.org/article/371eeff647184af7954c6350132ffa8b
Autor:
Anabella Smulever, Fabian Pitoia
Publikováno v:
Thyroid Research, Vol 16, Iss 1, Pp 1-11 (2023)
Abstract The detection of low-risk thyroid carcinoma has increased in recent decades, although disease-specific mortality remained without changes. The high prevalence of occult carcinomas in autopsy studies, and hence the underlying indolent course
Externí odkaz:
https://doaj.org/article/82f81140b25549d7b9d78d57536a5a11
Autor:
Anabella Smulever, Fabián Pitoia
Publikováno v:
Archives of Endocrinology and Metabolism
ABSTRACT Objectives To determine the percentage of patients with papillary thyroid carcinoma (PTC) who accepted active surveillance as an alternative to surgery in our clinical practice and to describe the clinical characteristics and outcomes of pat
Externí odkaz:
https://doaj.org/article/a4982f5e58f545efaaf96839c1fee028
Autor:
Fernanda Bueno, Anabella Smulever, Inés Califano, Jorgelina Guerra, Andrés Del Grecco, Juan Manuel Carrera, Raúl Giglio, Manglio Rizzo, Alejo Lingua, Ana Voogd, María del Carmen Negueruela, Erika Abelleira, Fabian Pitoia
Publikováno v:
Endocrine. 80:134-141
To present our real-life experience with dabrafenib and trametinib (D-T) treatment in patients with BRAF V600E-mutated ATC in Argentina.We included five patients from four different hospitals. The median age was 70 years, and 60% were male. The perfo
Autor:
Fernanda Bueno, Anabella Smulever, Inés Califano, Jorguelina Guerra, Andrés Del Grecco, Juan Manuel Carrera, Raúl Giglio, Manglio Rizzo, Alejo Lingua, Ana Voogd, María del Carmen Negueruela, Erika Abelleira, Fabián Pitoia
Purpose: To present our real-life experience with dabrafenib and trametinib (D-T) treatment in patients with BRAF V600E-mutated ATC in Argentina. Patients y methods: We included five patients from four different hospitals. The median age was 70 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90d1ded2bdefc2a36850a0e62bb28474
https://doi.org/10.21203/rs.3.rs-2169485/v1
https://doi.org/10.21203/rs.3.rs-2169485/v1
Autor:
Fabián Pitoia, Anabella Smulever
Publikováno v:
Endocrine. 72:505-512
To describe the clinical characteristics and outcomes of patients with cytologically Bethesda IV category (B IV) thyroid nodules who opted for active surveillance. We prospectively evaluated 155 patients with a single thyroid nodule classified as B I
Autor:
Anabella Smulever, Fabián Pitoia
Publikováno v:
World Journal of Clinical Oncology
In recent decades, while the incidence of thyroid cancer has increased exponentially around the world, mortality has remained stable. The vast majority of this increase is attributable to the identification of intrathyroidal papillary microcarcinomas
Autor:
Fabián Pitoia, Anabella Smulever
Publikováno v:
Endocrine. 69:587-595
To describe the outcomes and the incidence of adverse events following active surveillance (AS) versus immediate surgery in patients with low-risk papillary thyroid carcinoma (PTC). We prospectively evaluated 286 patients who attended the Hospital de
Publikováno v:
Revista Argentina de Endocrinología y Metabolismo. 54:69-75
Resumen En la actualidad, el enfoque terapeutico y el seguimiento de los pacientes con carcinoma diferenciado de tiroides (CDT) es individualizado de acuerdo con el riesgo de recurrencia de la enfermedad, con una menor tendencia a ablacionar a pacien
Autor:
Fernando Jerkovich, Gabriela Brenta, Fabián Pitoia, Anabella Smulever, Graciela Cross, Fernanda Bueno
Publikováno v:
European Thyroid Journal. 6:160-166
To evaluate the influence of age at diagnosis on the frequency of structural incomplete response (SIR) according to the modified risk of recurrence (RR) staging system from the American Thyroid Association guidelines.We performed a retrospective anal